Development and characterization of polyclonal antibodies against the linker region of the telomere-binding protein TRF2
Reprint PDF

Keywords

Chromosomes
Molecular cloning
Nuclear lamina
Nucleoprotein complexes
Polyclonal antibodies
Recombinant polypeptide
Shelterin
Telomere-binding protein
TRF2
Telomeres
Telomeric DNA
TTAGGG repeats

How to Cite

1.
Ilicheva N, Travina A, Voronin A, Podgornaya O. Development and characterization of polyclonal antibodies against the linker region of the telomere-binding protein TRF2. Electron. J. Biotechnol. [Internet]. 2018 Mar. 12 [cited 2024 Sep. 19];32. Available from: https://preprints.pucv.cl/index.php/ejbiotechnology/article/view/2017.12.001

Abstract

Background: TRF2 (telomeric repeat binding factor 2) is an essential component of the telomere-binding protein complex shelterin. TRF2 induces the formation of a special structure of telomeric DNA and counteracts activation of DNA damage-response pathways telomeres. TRF2 has a poorly characterized linker region (udTRF2) between its homodimerization and DNA-binding domains. Some lines of evidence have shown that this region could be involved in TRF2 interaction with nuclear lamina.

Results: In this study, the fragment of the TERF2 gene encoding udTRF2 domain of telomere-binding protein TRF2 was produced by PCR and cloned into the pET32a vector. The resulting plasmid pET32a-udTRF2 was used for the expression of the recombinant udTRF2 in E. coli RosettaBlue (DE3). The protein was isolated and purified using ammonium sulfate precipitation followed by ion-exchange chromatography. The purified recombinant protein udTRF2 was injected into guinea pigs to generate polyclonal antibodies. The ability of anti-udTRF2 antibodies to bind endogenous TRF2 in human skin fibroblasts was tested by western blotting and immunofluorescent staining.

Conclusions: In this study, the recombinant protein udTRF2 and antibodies to it were generated. Both protein and antibodies will provide a useful tool for investigation of the functions of the udTRF2 domain and its role in the interaction between TRF2 and nuclear lamina.

Reprint PDF

Upon acceptance of an article by the journal, authors will be asked to transfer the copyright to Electronic Journal of Biotechnology, which is committed to maintain the electronic access to the journal and to administer a policy of fair control and ensure the widest possible dissemination of the information. The author can use the article for academic purposes, stating clearly the following: "Published in Electronic Journal of Biotechnology at DOI:10.2225/volXX-issueX-fulltext-XX".

The Copyright Transfer Agreement must be submitted as a signed scanned copy to biotec@ucv.cl. All authors must send a copy of this document.